Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cdc25C interacts with PCNA at G2/M transition

Abstract

Cdc25 activates maturation promoting factor (MPF) and promotes mitosis by removing the inhibitory phosphate from the Tyr-15 of Cdc2 in human cells. In this study, we searched the interacting protein(s) of human Cdc25C using the yeast two-hybrid screen and identified proliferating cell nuclear antigen (PCNA) as an interacting partner of Cdc25C. The interaction between Cdc25C and PCNA was confirmed in vitro and in vivo. Co-immunoprecipitation analyses using human T cell line, Jurkat, further revealed that Cdc25C interacted with PCNA transiently when cells began to enter mitosis. Immunofluorescence analysis also showed that Cdc25C and PCNA were transiently co-localized in the nucleus at the beginning of M phase. Together with the previous observations of the interaction between various cdc/cyclin and PCNA, our findings strongly suggested a potential role of PCNA at the G2 to M phase transition of cell cycle.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

MPF:

maturation promoting factor

PCNA:

proliferating cell nuclear antigen

pol δ:

DNA polemerase δ

M:

mitosis

IPTG:

isopropyl β-D-thiogalactopyranoside; PI, propidium iodide

GST:

glutathione-S-transferase

OA:

okadaic acid

References

  • al-Khodairy F, Fotou E, Sheldrick KS, Griffiths DJ, Lehmann AR, Carr AM . 1994 Mol. Biol. Cell 5: 147–160

  • Allen JB, Zhou Z, Siede W, Friedberg EC, Elledge SJ . 1994 Genes Dev. 8: 2401–2415

  • Blasina A, de Weyer IV, Laus MC, Luyten WH, Parker AE, McGowan CH . 1999 Curr. Biol. 9: 1–10

  • Boddy MN, Furnari B, Mondesert O, Russell P . 1998 Science 280: 909–912

  • Chen U, Chen S, Saha P, Dutta A . 1996 Proc. Natl. Acad. Sci. USA 93: 11597–11602

  • Cheng J, Haas M . 1990 Mol. Cell. Biol. 10: 5502–5509

  • Furnari B, Blasina A, Boddy MN, McGowan CH, Russell P . 1999 Mol. Biol. Cell 10: 833–845

  • Gary R, Ludwig DL, Cornelius HL, MacInnes MA, Park MS . 1997 J. Biol. Chem. 272: 24522–24529

  • Gould KL, Nurse P . 1989 Nature 342: 39–45

  • Gowdy PM, Anderson HJ, Roberge M . 1998 J. Cell Sci. 111: 3401–3410

  • Hartwell LH, Kastan MB . 1994 Science 266: 1821–1828

  • Hindges R, Hubscher U . 1997 Biol. Chem. 378: 345–362

  • Kajino S, Suganuma M, Teranishi F, Takahashi N, Tetsuka T, Ohara H, Itoh M, Okamoto T . 2000 Oncogene 19: 2233–2239

  • Kawabe T, Muslin AJ, Korsmeyer SJ . 1997 Nature 385: 454–458

  • Krek W, Marks J, Schmitz N, Nigg EA, Simanis V . 1992 J. Cell Sci. 102: 43–53

  • Kumagai A, Dunphy WG . 1992 Cell 70: 139–151

  • Kumagai A, Dunphy WG . 1996 Science 273: 1377–1380

  • Labbe JC, Capony JP, Caput D, Cavadore JC, Derancourt J, Kaghad M, Lelias JM, Picard A, Doree M . 1989 EMBO J. 8: 3053–3058

  • Levine AJ . 1997 Cell 88: 323–331

  • Lindsay HD, Griffiths DJ, Edwards RJ, Christensen PU, Murray JM, Osman F, O'Connell MJ, Raleigh JM, Verkade HM, Nurse P . 1997 EMBO J. 16: 545–554

  • Loor G, Zhang SJ, Zhang P, Toomey NL, Lee MY . 1997 Nucleic Acids Res. 25: 5041–5046

  • Lopez-Girona A, Furnari B, Mondesert O, Russell P . 1999 Nature 397: 172–175

  • Medema RH, Klompmaker R, Smits VA, Rijksen G . 1998 Oncogene 16: 431–441

  • Moreno S, Hayles J, Nurse P . 1989 Cell 58: 361–372

  • Nakanishi M, Robetorye RS, Pereira-Smith OM, Smith JR . 1995 J. Biol. Chem. 270: 17060–17063

  • Nurse P . 1997 Cell 91: 865–867

  • O'Connell MJ, Raleigh JM, Verkade HM, Nurse P . 1997 EMBO J. 16: 545–554

  • Parker LL, Piwnica-Worms H . 1992 Science 257: 1955–1957

  • Paulovich AG, Hartwell LH . 1995 Cell 82: 841–847

  • Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H . 1997 Science 277: 1501–1505

  • Pines J, Hunter T . 1989 Cell 58: 833–846

  • Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B . 1987 Nature 326: 517–520

  • Prosperi E . 1997 Prog. Cell Cycle Res. 3: 193–210

  • Russell P . 1998 Trends Biochem Sci. 23: 399–402

  • Russell P, Nurse P . 1986 Cell 45: 145–153

  • Sadhu K, Reed SI, Richardson H, Russell P . 1990 Proc. Natl. Acad. Sci. USA 87: 5139–5143

  • Suganuma M, Kawabe T, Hori H, Funabiki T, Okamoto T . 1999 Cancer Res. 59: 5887–5891

  • Szepesi A, Gelfand EW, Lucas JJ . 1994 Blood 84: 3413–3421

  • Tan CK, Castillo C, So AG, Downey KM . 1986 J. Biol. Chem. 261: 12310–12316

  • Tetsuka T, Uranishi H, Imai H, Ono T, Sonta S, Takahashi N, Asamitsu K, Okamoto T . 2000 J. Biol. Chem. 275: 4383–4390

  • Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E . 1998 EMBO J. 17: 2728–2735

  • Uranishi H, Tetsuka T, Yamashita M, Asamitsu K, Shimizu M, Itoh M, Okamoto T . 2001 J. Biol. Chem. 276: 13395–13401

  • Walworth N, Davey S, Beach D . 1993 Nature 363: 368–371

  • Walworth NC, Bernards R . 1996 Science 271: 353–356

  • Warbrick E . 1998 Bioessays 20: 195–199

  • Warbrick E, Lane DP, Glover DM, Cox LS . 1997 Oncogene 14: 2313–2321

  • Weinert TA, Kiser GL, Hartwell LH . 1994 Genes Dev. 8: 652–665

  • Xiong Y, Zhang H, Beach D . 1992 Cell 71: 505–514

  • Yamashita K, Yasuda H, Pines J, Yasumoto K, Nishitani H, Ohtsubo M, Hunter T, Sugimura T, Nishimoto T . 1990 EMBO J. 9: 4331–4338

  • Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T . 1999 Oncogene 18: 5177–5186

  • Yao SL, Akhtar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ, Bedi A . 1996 Nat. Med. 2: 1140–1143

  • Zeng XR, Hao H, Jiang Y, Lee MY . 1994 J. Biol. Chem. 269: 24027–24033

  • Zeng Y, Forbes KC, Wu Z, Moreno S, Piwnica-Worms H, Enoch T . 1998 Nature 395: 507–510

Download references

Acknowledgements

We thank Drs P Russell, H Piwnica-Worms and M Nakanishi for the kind gifts of PBSK1, anti-Cdc25C antibody and pGEX-PCNA. This work was supported by Grant-in-aid for exploratory research, a part of Grants from the Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Aichi Cancer Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Okamoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawabe, T., Suganuma, M., Ando, T. et al. Cdc25C interacts with PCNA at G2/M transition. Oncogene 21, 1717–1726 (2002). https://doi.org/10.1038/sj.onc.1205229

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205229

Keywords

This article is cited by

Search

Quick links